Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Feb;27(2):197–202. doi: 10.1128/aac.27.2.197

Structure-activity studies on phosphonoacetate.

J C Mao, E R Otis, A M von Esch, T R Herrin, J S Fairgrieve, N L Shipkowitz, R G Duff
PMCID: PMC176237  PMID: 2984985

Abstract

Phosphonoacetic acid is a selective antiherpesvirus agent. More than 100 congeners of phosphonoacetic acid were evaluated in vitro and in vivo to understand structure-activity relationships in the hope of designing a superior analog. Results showed that the antiherpesvirus activity had highly specific structural requirements. Neither the carboxylic nor the phosphono groups could be replaced. The distance between these two groups is important. Increase of this distance caused complete loss of activity. However, if this distance was maintained, the addition of groups to the methylene carbon resulted in a reduction, but not loss, of activity. On the other hand, decrease of the carbon chain to formic acid did not deteriorate its antiherpes activity. All analogs tested had lower activity than the parent compound. However, some compounds with decreased activity in vitro appeared to have favorable pharmacological properties in vivo.

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolden A., Aucker J., Weissbach A. Synthesis of herpes simplex virus, vaccinia virus, and adenovirus DNA in isolated HeLa cell nuclei. I. Effect of viral-specific antisera and phosphonoacetic acid. J Virol. 1975 Dec;16(6):1584–1592. doi: 10.1128/jvi.16.6.1584-1592.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collins K. D., Stark G. R. Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. J Biol Chem. 1971 Nov;246(21):6599–6605. [PubMed] [Google Scholar]
  3. Eriksson B., Larsson A., Helgstrand E., Johansson N. G., Oberg B. Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. Biochim Biophys Acta. 1980 Mar 28;607(1):53–64. doi: 10.1016/0005-2787(80)90220-8. [DOI] [PubMed] [Google Scholar]
  4. Fitzwilliam J. F., Griffith J. F. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid. J Infect Dis. 1976 Jun;133 (Suppl):A221–A225. doi: 10.1093/infdis/133.supplement_2.a221. [DOI] [PubMed] [Google Scholar]
  5. Gerstein D. D., Dawson C. R., O J. O. Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis. Antimicrob Agents Chemother. 1975 Mar;7(3):285–288. doi: 10.1128/aac.7.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hay J., Subak-Sharpe J. H. Mutants of herpes simplex virus types 1 and 2 that are resistant to phosphonoacetic acid induce altered DNA polymerase activities in infected cells. J Gen Virol. 1976 Apr;31(1):145–148. doi: 10.1099/0022-1317-31-1-145. [DOI] [PubMed] [Google Scholar]
  7. Helgstrand E., Eriksson B., Johansson N. G., Lannerö B., Larsson A., Misiorny A., Norén J. O., Sjöberg B., Stenberg K., Stening G. Trisodium phosphonoformate, a new antiviral compound. Science. 1978 Sep 1;201(4358):819–821. doi: 10.1126/science.210500. [DOI] [PubMed] [Google Scholar]
  8. Herrin T. R., Fairgrieve J. S., Bower R. R., Shipkowitz N. L. Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid. J Med Chem. 1977 May;20(5):660–663. doi: 10.1021/jm00215a008. [DOI] [PubMed] [Google Scholar]
  9. Huang E. S. Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. J Virol. 1975 Dec;16(6):1560–1565. doi: 10.1128/jvi.16.6.1560-1565.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klein R. J., Friedman-Kien A. E. Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice. Antimicrob Agents Chemother. 1975 Mar;7(3):289–293. doi: 10.1128/aac.7.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lee L. F., Nazerian K., Leinbach S. S., Reno J. M., Boezi J. A. Effect of phosphonoacetate on Marek's disease virus replication. J Natl Cancer Inst. 1976 Apr;56(4):823–827. doi: 10.1093/jnci/56.4.823. [DOI] [PubMed] [Google Scholar]
  12. Leinbach S. S., Reno J. M., Lee L. F., Isbell A. F., Boezi J. A. Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase. Biochemistry. 1976 Jan 27;15(2):426–430. doi: 10.1021/bi00647a029. [DOI] [PubMed] [Google Scholar]
  13. Mao J. C., Robishaw E. E. Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate. Biochemistry. 1975 Dec 16;14(25):5475–5479. doi: 10.1021/bi00696a015. [DOI] [PubMed] [Google Scholar]
  14. Meyer R. F., Varnell E. D., Kaufman H. E. Phosphonoacetic acid in the treatment of experimental ocular herpes simplex infections. Antimicrob Agents Chemother. 1976 Feb;9(2):308–311. doi: 10.1128/aac.9.2.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nyormoi O., Thorley-Lawson D. A., Elkington J., Strominger J. L. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. Proc Natl Acad Sci U S A. 1976 May;73(5):1745–1748. doi: 10.1073/pnas.73.5.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Overall J. C., Jr, Kern E. R., Glasgow L. A. Effective antiviral chemotherapy in cytomegalovirus infection of mice. J Infect Dis. 1976 Jun;133 (Suppl):A237–A244. doi: 10.1093/infdis/133.supplement_2.a237. [DOI] [PubMed] [Google Scholar]
  17. Overby L. R., Duff R. G., Mao J. C. Antiviral potential of phosphonoacetic acid. Ann N Y Acad Sci. 1977 Mar 4;284:310–320. doi: 10.1111/j.1749-6632.1977.tb21966.x. [DOI] [PubMed] [Google Scholar]
  18. Overby L. R., Robishaw E. E., Schleicher J. B., Rueter A., Shipkowitz N. L., Mao J. C. Inhibition of herpes simplex virus replication by phosphonoacetic acid. Antimicrob Agents Chemother. 1974 Sep;6(3):360–365. doi: 10.1128/aac.6.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sabourin C. L., Reno J. M., Boezi J. A. Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate. Arch Biochem Biophys. 1978 Apr 15;187(1):96–101. doi: 10.1016/0003-9861(78)90010-3. [DOI] [PubMed] [Google Scholar]
  20. Shipkowitz N. L., Bower R. R., Appell R. N., Nordeen C. W., Overby L. R., Roderick W. R., Schleicher J. B., Von Esch A. M. Suppression of herpes simplex virus infection by phosphonoacetic acid. Appl Microbiol. 1973 Sep;26(3):264–267. doi: 10.1128/am.26.3.264-267.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Summers W. C., Klein G. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. J Virol. 1976 Apr;18(1):151–155. doi: 10.1128/jvi.18.1.151-155.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Thorley-Lawson D., Strominger J. L. Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid. Nature. 1976 Sep 23;263(5575):332–334. doi: 10.1038/263332a0. [DOI] [PubMed] [Google Scholar]
  23. Wohlenberg C. R., Walz M. A., Notkins A. L. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia. Infect Immun. 1976 May;13(5):1519–1521. doi: 10.1128/iai.13.5.1519-1521.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yajima Y., Tanaka A., Nonoyama M. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid. Virology. 1976 May;71(1):352–354. doi: 10.1016/0042-6822(76)90119-7. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES